deltatrials

Diabetes Trials in Cuernavaca, Mexico

Conditions / Diabetes / Cuernavaca, Mexico

Clinical trials for Diabetes investigate a range of treatment strategies and patient populations.

13 total trials for this combination

Showing top 10 of 13 trials

Trials

NCT ID Title Status Phase
NCT02501161 A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus COMPLETED PHASE3
NCT02100475 A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification COMPLETED PHASE3
NCT01952145 A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus COMPLETED PHASE3
NCT03136484 Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes COMPLETED PHASE3
NCT02294123 Glycemic Index and Insulinemic Index of 3 Types of Tortilla in Mexican Adults COMPLETED NA
NCT02247635 Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican Women COMPLETED NA
NCT00294723 To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c TERMINATED PHASE3
NCT01720446 Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes COMPLETED PHASE3
NCT00313313 A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas COMPLETED PHASE3
NCT01959529 A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events COMPLETED PHASE3

Related Pages